Last reviewed · How we verify

NCT05646160: MTRPs

Effects of MTRPs Therapy in Migraine.

Status unknown NA Last updated 2 March 2023
What this trial tests

NA trial testing Ischemic Compression of Myofascial Trigger Points (IC-MTRPs) in Migraine in 100 participants. Status unknown.

Timeline
15 January 2018
Primary endpoint
1 March 2023
2 March 2023

Quick facts

Lead sponsorJózef Piłsudski University of Physical Education
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date15 January 2018
Primary completion1 March 2023
Estimated completion2 March 2023
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Józef Piłsudski University of Physical Education

Who can join

Adults 18 to 65, female only, with Migraine or Pain, Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Case series, repeated-measures design, pilot study. Adult, female, migraine patients underwent seven Ischemic Compression Myofascial Trigger Points (IC-MTrPs) therapy sessions. The aim of the study is to investigate whether therapy of the shoulder girdle and neck muscles by deactivating MTrPs causes modification of biomechanical and biochemical variables in the blood and reduces headache in people with migraine, improving their quality of life by improving their health. People qualified for the study were divided into 3 groups according to the type of migraine: 1. CM group - patients with chronic migraine 2. EMa group - patients with paroxysmal migraine with aura 3. EMb group - patients with paroxysmal migraine without an aura. All patients underwent 7 interventions in the area of the muscles of the shoulder girdle and neck (by deactivating trigger points) performed every 2 or 3 days. They did not take any headache medications during the treatment period. However, during a migraine attack, they could undergo treatments and research measurements. Biomechanical measurements of the cervical spine, shoulder girdle muscles and blood chemistry were performed before, during and after the patients' therapy. All treatments were performed on the following muscles: * m. trapesius pars descendent (trapezius upper), * m. sternocleidomastoideus (sternocleidomastoid), * m. temporalis (temporal), * m. legator scapulae (levator scapula), * m. supraspinatus (supraspinatus), * m. suboccipitales (suboccipital).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Myofascial trigger points therapy increases neck mobility and reduces headache pain in migraine patients - pilot study.
    Olesiejuk M, Chalimoniuk M, Sacewicz T. · · 2025 · cited 1× · PMID 39893364 · DOI 10.1186/s12891-025-08360-1

Verify or expand the search:

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other Józef Piłsudski University of Physical Education trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05646160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing